APA (7th ed.) Citation

Yalcin, A. D., & Herth, F. (2013). Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels. Expert opinion on biological therapy, 13(9), . https://doi.org/10.1517/14712598.2013.819338

Chicago Style (17th ed.) Citation

Yalcin, Arzu Didem, and Felix Herth. "Omalizumab Is Effective in Treating Severe Asthma in Patients with Severe Cardiovascular Complications and Its Effects on SCD200, D-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β Levels." Expert Opinion on Biological Therapy 13, no. 9 (2013). https://doi.org/10.1517/14712598.2013.819338.

MLA (9th ed.) Citation

Yalcin, Arzu Didem, and Felix Herth. "Omalizumab Is Effective in Treating Severe Asthma in Patients with Severe Cardiovascular Complications and Its Effects on SCD200, D-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β Levels." Expert Opinion on Biological Therapy, vol. 13, no. 9, 2013, https://doi.org/10.1517/14712598.2013.819338.